The Net Margin of Chengdu Easton Biopharmaceuticals Co Ltd (688513.SS) is 21.33%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | 21.33% |
| 2024-12-31 | 17.63% |
| 2023-12-31 | 20.28% |
| 2022-12-31 | 21.06% |
| 2021-12-31 | 22.72% |
| 2020-12-31 | 19.33% |
| 2019-12-31 | 11.47% |
| 2018-12-31 | 17.56% |
| 2017-12-31 | 13.52% |